Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2026 16:05 ET | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics to Participate in Upcoming May Events

NEW HAVEN, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...
April 23, 2026 15:53 ET | Source: The ROOT Brands

The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products

Franklin, Tennessee, April 23, 2026 (GLOBE NEWSWIRE) -- The ROOT Brands, a patent‑driven consumer wellness company built on science‑backed innovation and cellular health research, announced today...
April 23, 2026 15:46 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

Regeneron will provide Otarmeni™ (lunsotogene parvec-cwha), its recently approved gene therapy for an ultra-rare form of genetic hearing loss, for free in the U.S. Regeneron will lower Medicaid...
April 23, 2026 15:45 ET | Source: Oxford Treatment Center

This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction

Oxford Treatment Center sounds warning this Alcohol Awareness Month, citing rise in patients seeking alcohol addiction treatment.
April 23, 2026 15:38 ET | Source: Cook County Health

Cook County Health Recognizes 60th Anniversary of Trauma Unit

Chicago, IL, April 23, 2026 (GLOBE NEWSWIRE) -- On April 23, Cook County Health proudly celebrated the 60th anniversary of the Trauma & Burn Department at John H. Stroger, Jr. Hospital, honoring...
April 23, 2026 14:03 ET | Source: BCC Research LLC

AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption

AI-driven monitoring is increasingly used to improve precision, efficiency, and safety in spine, neurosurgical, and ENT procedures.
April 23, 2026 13:13 ET | Source: Grace Therapeutics, Inc.

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information FDA Does not Request Additional Clinical Data Company...
April 23, 2026 12:14 ET | Source: PridCor Therapeutics, LLC

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses

PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.
April 23, 2026 12:02 ET | Source: Johnson & Johnson EMEA

IMAAVY® (nipocalimab)▼shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ Patients...
April 23, 2026 12:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an immediate...